PharmaDrug Strikes Deal With Johns Hopkins University For A Clinical Trial Into Psychedelic DMT
On Wednesday, PharmaDrug Inc. (CSE: PHRX) (OTCPINK: LMLLF), a company researching DMT and other psychedelics for medical purposes, announced a new clinical trial agreement with Johns Hopkins University, one of the leading research institutions in the space.